Erlotinib Recruiting Phase 2 Trials for Stage IIIA Non-Small Cell Lung Cancer / Stage IIIb Non-small Cell Lung Cancer Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01857271Erlotinib Hydrochloride Before Surgery in Treating Patients With Stage III Non-Small Cell Lung Cancer